Analyst firms · Cantor Fitzgerald · CAPR
Cantor Fitzgerald CAPR price target and rating history
Capricor Therapeutics Inc. (CAPR) · Health Care
Cantor Fitzgerald rates Capricor Therapeutics Inc. (CAPR) Overweight with a $28 price target, as of its latest action on Aug 14, 2026. It has published 3 rating actions on CAPR since January 2024, including 1 upgrade and 1 downgrade. Across 6 firms with a CAPR price target in the last 12 months, the median target is $23. Cantor Fitzgerald's $28 is 22% above that.
- Current rating
- Overweight
- Price target
- $28
- Median target, all firms
- $23
- Actions on CAPR
- 3
Cantor Fitzgerald price target on CAPR
Every Cantor Fitzgerald rating on CAPR
- Aug 14, 2026
- Jul 30, 2026
- Jan 5, 2024
How other firms rate CAPR
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| B. Riley Securities | Buy | $21 | Sep 14, 2026 |
| Piper Sandler | Overweight | $25 | Sep 1, 2026 |
| Oppenheimer | Outperform | $54 | Aug 25, 2026 |
| Cantor Fitzgerald | Overweight | $28 | Aug 14, 2026 |
| Maxim Group | Hold | Jul 30, 2026 | |
| H.C. Wainwright | Neutral | Jul 30, 2026 | |
| Ladenburg Thalmann | Neutral | Jul 30, 2026 | |
| Alliance Global Partners | Neutral | $7 | Jul 28, 2026 |
| Roth Capital | Neutral | $7 | Jul 27, 2026 |
Questions about Cantor Fitzgerald and CAPR
- What is Cantor Fitzgerald's price target for CAPR?
- Cantor Fitzgerald's latest stated price target for Capricor Therapeutics Inc. (CAPR) is $28, from its action on Aug 14, 2026.
- What is Cantor Fitzgerald's rating on CAPR?
- Cantor Fitzgerald rates CAPR Overweight, a bullish rating, as of Aug 14, 2026.
- When did Cantor Fitzgerald last change its view on CAPR?
- On Aug 14, 2026, Cantor Fitzgerald upgrades to Overweight from Neutral, price target $28.
- How does Cantor Fitzgerald's CAPR target compare with other analysts?
- Across 6 firms with a CAPR price target in the last 12 months, the median target is $23. Cantor Fitzgerald's $28 is 22% above that.
More CAPR rating histories
All Cantor Fitzgerald ratingsCAPR news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.